₹ 2,502.50
45.30 (1.84%)
C
Caplin Point Laboratories
₹ 2,502.50
Caplin Point Laboratories EPS Summary (consolidated)
The latest quarterly EPS of Caplin Point Laboratories as of Q1 Jun 2026 stands at ₹23.27. This is a 3.98% growth quarter on quarter and 15.77% growth same quarter last year. For the FY2026 the EPS of Caplin Point Laboratories stands at ₹84.36. This is a 19.54% growth compared with FY2025.
Caplin Point Laboratories EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

